ASCO: Expression of end-binding protein 1 (EB1), a potential response-predictive biomarker for lisavanbulin, in glioblastoma and various other solid tumor types Date Published: View Poster: https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.3118
